1Nursing Program, Loyola University, New Orleans, LA, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
New triple-drug HIV therapy, combining two nucleoside analogues and a protease inhibitor, effectively reduces viral load and improves CD4+ counts. This approach delays disease progression in patients at all stages of HIV infection.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: